Skip to main content
Top
Published in: Diabetology & Metabolic Syndrome 1/2015

01-12-2015 | Meeting abstract

Frequency of metabolic syndrome in obesity: a comparison of current criteria of IDF and NCEP-ATPIII

Authors: Luana Costa Nascimento, Mayne Batista Fontes Santos, Alexandre Rocha Andrade, Josilda Ferreira Cruz, Ana Denise Costa de Oliveira, Karla Freire Rezende, Rubens Cruz Silva Filho

Published in: Diabetology & Metabolic Syndrome | Special Issue 1/2015

Login to get access

Excerpt

Obesity appears as a worldwide epidemic, causing concerns and burden to public health. A very damaging complication of obesity is its relationship with the increase of the cardiovascular risk. We analyzed the association between obesity and the diagnosis of metabolic syndrome (MS) by following the two criteria in effect: NCEP-ATPIII and IDF. …
Metadata
Title
Frequency of metabolic syndrome in obesity: a comparison of current criteria of IDF and NCEP-ATPIII
Authors
Luana Costa Nascimento
Mayne Batista Fontes Santos
Alexandre Rocha Andrade
Josilda Ferreira Cruz
Ana Denise Costa de Oliveira
Karla Freire Rezende
Rubens Cruz Silva Filho
Publication date
01-12-2015
Publisher
BioMed Central
Published in
Diabetology & Metabolic Syndrome / Issue Special Issue 1/2015
Electronic ISSN: 1758-5996
DOI
https://doi.org/10.1186/1758-5996-7-S1-A148

Other articles of this Special Issue 1/2015

Diabetology & Metabolic Syndrome 1/2015 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine